According to a number of studies, SCD1 inhibitors in ovarian cancer can dramatically increase the effect of ferroptosis and aid in tumor cell regression, in addition to increasing the sensitivity of ferroptosis inducers. The gene discussed is SCD; the disease is ovarian cancer.